Andre T, Tougeron D, Piessen G, de la Fouchardiere C, et al. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized
Deficient Mismatch Repair/Microsatellite Instability-High Gastric or
Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. J Clin Oncol 2023;41:255-265.
PMID: 35969830